Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury.
Keiko SuzukiHideshi OkadaHiroyuki TomitaKazuyuki SumiYoshinori KakinoRyu YasudaYuichiro KitagawaTetsuya FukutaTakahito MiyakeShozo YoshidaAkio SuzukiShinji OguraPublished in: Thrombosis journal (2021)
In this case report, changes in serum SDC-1 level closely reflected the change in disease condition in a patient with COVID-19. Serum SDC-1 may be a useful biomarker for monitoring the disease state of critically ill patients with COVID-19.